Brief: Viva Biotech Holdings Says Deloitte Touche Tohmatsu Will Retire As Auditor
07/05/2020 16:13
May 7 (Reuters) - VIVA Biotech Holdings 1873.HK :
* DELOITTE TOUCHE TOHMATSU WILL RETIRE AS AUDITOR
* RESOLVED ERNST & YOUNG BE TO BE APPOINTED AS AUDITOR
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5bDwkw
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical